Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Nicoletta Vivona"'
1
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma
Autor: Nicoletta Vivona, Manuela Labbozzetta, Natale D'Alessandro, Rossana Porcasi, Paola Poma, Monica Notarbartolo
Publikováno v: OMICS: A Journal of Integrative Biology. 16:579-588
Raf-1 kinase inhibitor protein (RKIP) is a tumor and metastasis suppressor that promotes drug-induced apoptosis in cancer cells. It is frequently downregulated, both at the mRNA and protein level, in hepatocellular carcinoma (HCC), but the mechanisms
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037efdb43f1122377ffbf854e4b84cfa
https://doi.org/10.1089/omi.2012.0048
Zobrazit plný text záznamu
2
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma
Autor: Manuela Labbozzetta, Giuseppe Montalto, Natale D'Alessandro, Vito M. R. Muggeo, Paola Poma, Rossana Porcasi, Monica Notarbartolo, Lydia Giannitrapani, Ada Maria Florena, Melchiorre Cervello, Nicoletta Vivona, Luigi Sandonato
Publikováno v: OMICS: A Journal of Integrative Biology. 15:267-272
The transcription factor Yin Yang 1 (YY1) can favor several aspects of tumorigenesis. In turn, Raf-1 Kinase Inhibitor Protein (RKIP) inhibits the oncogenic activities of MAPK and NF-κB pathways and promotes drug-induced apoptosis. Mutual influences
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f99e3890505af2925ad193a4641855
https://doi.org/10.1089/omi.2010.0096
Zobrazit plný text záznamu
3
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells
Autor: Manuela Labbozzetta, Monica Notarbartolo, Alessandro Gulino, Paola Poma, Natale D'Alessandro, Nicoletta Vivona
Raf-1 kinase inhibitor protein (RKIP) is a tumor suppressor and metastasis inhibitor, which enhances drug-induced apoptosis of cancer cells. Downregulation of RKIP may be significant in the biology of highly aggressive and drug-resistant tumors, for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116f62508300614a9ab3680595adc9ee
https://europepmc.org/articles/PMC4665334/
Zobrazit plný text záznamu
4
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors
Autor: Monica Notarbartolo, Natale D'Alessandro, Nicoletta Vivona, Manuela Labbozzetta, Paola Poma
Triple-negative breast cancers (TNBCs) are a heterogenous group of breast cancers characterized by poor prognosis because they are not amenable to targeted therapies. We have taken into account that altered expression of Raf-1 kinase inhibitor protei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664edf04f2fe3a391eae86e7f1b3a114
http://hdl.handle.net/10447/147425
Zobrazit plný text záznamu
5
[Untitled]
Autor: Alberto Notarbartolo, F. Polizzi, Francesco Onorato, Nicoletta Vivona, Rosalia Caldarella, M. Severino, Carlo M. Barbagallo, Maurizio Averna, Davide Noto, Manfredi Rizzo, Angelo B. Cefalù
Publikováno v: European Journal of Epidemiology. 17:707-713
Polymorphisms of apoE gene are able to modulate lipoprotein metabolism at different steps and to influence LDL-cholesterol (LDL-C) levels and also other lipoproteins features. Population studies documented large differences in the frequency of apoE a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ad72de261cbfbe99ba0f835e5c784c94
https://doi.org/10.1023/a:1015618216828
Zobrazit plný text záznamu
7
Two Italian kindreds carrying the Arg136--Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele
Autor: Livia Pisciotta, Giovanni Emmanuele, V. Guido, M. Rolleri, Alberto Notarbartolo, S. Travali, Maurizio Averna, Carlo M. Barbagallo, Davide Noto, Stefano Bertolini, B. Fiore, Angelo B. Cefalù, Nicoletta Vivona
Publikováno v: Nutrition, metabolism, and cardiovascular diseases : NMCD. 13(2)
Background and Aims: Type III hyperlipoproteinemia, or dysbetalipoproteinemia, is commonly associated with apolipoprotein E2 homozygosity (Cy Background and Aims: 12, Cy Background and Aims: 58). Apo E2-Christchurch (Arg136→Ser), a rare mutation of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b02b3ac459c96b57c8f1069464dff12
https://pubmed.ncbi.nlm.nih.gov/12929622
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje